Litcius/Paper detail

Pirtobrutinib: First Approval

Susan J. Keam

2023Drugs47 citationsDOIOpen Access PDF

Topics & Concepts

Bruton's tyrosine kinaseMedicineMantle cell lymphomaRefractory (planetary science)Drug approvalIbrutinibClinical trialInternal medicineOncologyPharmacologyLymphomaTyrosine kinaseDrugLeukemiaChronic lymphocytic leukemiaReceptorPhysicsAstrobiologyChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentViral-associated cancers and disorders
Pirtobrutinib: First Approval | Litcius